Ramosetron: International drug information (concise)

For abbreviations, symbols, and age group definitions used in Lexicomp (show table)

International Brand Names

International Brand Names by Country

For country code abbreviations (show table)

(CN) China: Nasea;
(ID) Indonesia: Nasea | Ramozea;
(IN) India: Ibset | Nozia;
(JP) Japan: Irribow | Nasea | Nasea od | Ramosetron HCL | Ramosetron Hcl Sandoz;
(KR) Korea, Republic of: Emestop | Emestop FDT | Irribow | Nasea | Nasea od | Naseron | Naseron od | Ramea | Ramocan | Ramovy | Ramset | Ramtron;
(PH) Philippines: Nasea;
(TH) Thailand: Irribow | Nasea;
(TW) Taiwan: Setoral

Index Terms

Pharmacologic Category

Reported Use

Prevention of chemotherapy-induced or postoperative nausea and vomiting; treatment of irritable bowel syndrome with diarrhea

Dosage Range

Adults:

Irritable bowel syndrome with diarrhea: Oral (tablet):

Females: 2.5 to 5 mcg once daily (maximum: 5 mcg/day).

Males: 2.5 to 10 mcg once daily (maximum: 10 mcg/day).

Prevention of chemotherapy-induced nausea and vomiting:

Oral (orally disintegrating tablet): 100 mcg once daily administered 1 hour prior to chemotherapy.

IV: 300 to 600 mcg once daily (maximum: 600 mcg/day).

Prevention of postoperative nausea and/or vomiting: IV: 300 to 600 mcg once daily (maximum: 600 mcg/day).

Product Availability

Product available in various countries; not currently available in the US

Dosage Forms

Solution, Intravenous: 300 mcg/2 mL (2 mL)

Tablet, Oral: 2.5 mcg, 5 mcg

Tablet Dispersable, Oral: 100 mcg

Topic 10501 Version 49.0